Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2018 Filed May 22, 2018 23:03 UTC |
Winningham Rick EDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 67,617 | $24.31 | $1,643,769.27 |
DisclosureSEC source: 0001179110-18-007376 · edgar.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 919,620 Read SEC document |
| May 20, 2018 Filed May 22, 2018 23:02 UTC |
PASQUALONE FRANKSVP, Chief Comm Ops Officer
|
Tax withholdingOrdinary Shares | 18,424 | $24.31 | $447,887.44 |
DisclosureSEC source: 0001179110-18-007373 · edgar.xml · nonDerivative · entry 1 PASQUALONE FRANK · CIK 0001597334 · SVP, Chief Comm Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,810 Read SEC document |
| May 20, 2018 Filed May 22, 2018 23:01 UTC |
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc
|
Tax withholdingOrdinary Shares | 26,991 | $24.31 | $656,151.21 |
DisclosureSEC source: 0001179110-18-007371 · edgar.xml · nonDerivative · entry 1 HAUMANN BRETT K · CIK 0001607733 · SVP Clin Dev & Chief Med Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,962 Read SEC document |
| May 20, 2018 Filed May 22, 2018 23:01 UTC |
GALA RENEE DSVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 21,230 | $24.31 | $516,101.30 |
DisclosureSEC source: 0001179110-18-007370 · edgar.xml · nonDerivative · entry 2 GALA RENEE D · CIK 0001607737 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,792 Read SEC document |
| May 18, 2018 Filed May 22, 2018 23:01 UTC |
GALA RENEE DSVP, Chief Financial Officer
|
SaleOrdinary Shares | 10,000 | $24.29 | $242,877.00 |
DisclosureSEC source: 0001179110-18-007370 · edgar.xml · nonDerivative · entry 1 GALA RENEE D · CIK 0001607737 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,022 F1 · price: This transaction was executed in multiple trades at prices from $24.14 to $24.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 14, 2018 Filed May 16, 2018 19:03 UTC |
HEGDE SHARATHCHANDRA SSVP, Research
|
GrantOrdinary Shares | 33,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006936 · edgar.xml · nonDerivative · entry 1 HEGDE SHARATHCHANDRA S · CIK 0001668696 · SVP, Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,361 F1 · shares: On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On May 14, 2018, the performance conditions applicable to 33,750 shares were achieved and such shares will vest on May 20, 2018. Read SEC document |
| May 14, 2018 Filed May 16, 2018 19:05 UTC |
WORBOYS PHILIP DSVP, Translational Science
|
GrantOrdinary Shares | 33,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006941 · edgar.xml · nonDerivative · entry 1 WORBOYS PHILIP D · CIK 0001668718 · SVP, Translational Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,178 F1 · shares: On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On May 14, 2018, the performance conditions applicable to 33,750 shares were achieved and such shares will vest on May 20, 2018. F2 · balance_after: Includes 865 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2018. Read SEC document |
| May 14, 2018 Filed May 16, 2018 19:04 UTC |
PITZER KENNETH RSVP, Prod Strat & Comm Plng
|
GrantOrdinary Shares | 33,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006938 · edgar.xml · nonDerivative · entry 1 PITZER KENNETH R · CIK 0001668775 · SVP, Prod Strat & Comm Plng 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,804 F1 · shares: On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On May 14, 2018, the performance conditions applicable to 33,750 shares were achieved and such shares will vest on May 20, 2018. Read SEC document |
| May 14, 2018 Filed May 16, 2018 19:04 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
GrantOrdinary Shares | 33,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006939 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,276 F1 · shares: On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On May 14, 2018, the performance conditions applicable to 33,750 shares were achieved and such shares will vest on May 20, 2018. F2 · balance_after: Includes 865 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2018. Read SEC document |
| May 14, 2018 Filed May 16, 2018 23:05 UTC |
Winningham Rick EDirector · Chief Executive Officer
|
GrantOrdinary Shares | 105,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006940 · edgar.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 987,237 F1 · shares: On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On May 14, 2018, the performance conditions applicable to 105,000 shares were achieved and such shares will vest on May 20, 2018. F2 · balance_after: Includes 865 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2018. Read SEC document |
| May 14, 2018 Filed May 16, 2018 23:04 UTC |
PASQUALONE FRANKSVP, Chief Comm Ops Officer
|
GrantOrdinary Shares | 33,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006937 · edgar.xml · nonDerivative · entry 1 PASQUALONE FRANK · CIK 0001597334 · SVP, Chief Comm Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,234 F1 · shares: On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On May 14, 2018, the performance conditions applicable to 33,750 shares were achieved and such shares will vest on May 20, 2018. F2 · balance_after: Includes 865 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2018. Read SEC document |
| May 14, 2018 Filed May 16, 2018 23:03 UTC |
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc
|
GrantOrdinary Shares | 33,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006935 · edgar.xml · nonDerivative · entry 1 HAUMANN BRETT K · CIK 0001607733 · SVP Clin Dev & Chief Med Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,953 F1 · shares: On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On May 14, 2018, the performance conditions applicable to 33,750 shares were achieved and such shares will vest on May 20, 2018. Read SEC document |
| May 14, 2018 Filed May 16, 2018 23:03 UTC |
GALA RENEE DSVP, Chief Financial Officer
|
GrantOrdinary Shares | 33,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006934 · edgar.xml · nonDerivative · entry 1 GALA RENEE D · CIK 0001607737 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,022 F1 · shares: On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On May 14, 2018, the performance conditions applicable to 33,750 shares were achieved and such shares will vest on May 20, 2018. F2 · balance_after: Includes 865 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2018. Read SEC document |
| May 01, 2018 Filed May 3, 2018 22:13 UTC |
Gunderson Robert V JRDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $24.43 | $0.00 |
DisclosureSEC source: 0001179110-18-006189 · edgar.xml · derivative · entry 3 Gunderson Robert V JR · CIK 0001302450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2028-04-30 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 22:13 UTC |
Gunderson Robert V JRDirector
|
GrantOrdinary Shares | 8,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006189 · edgar.xml · nonDerivative · entry 1 Gunderson Robert V JR · CIK 0001302450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,245 Read SEC document |
| May 01, 2018 Filed May 3, 2018 18:20 UTC |
WHITESIDES GEORGE MDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $24.43 | $0.00 |
DisclosureSEC source: 0001179110-18-006196 · edgar.xml · derivative · entry 4 WHITESIDES GEORGE M · CIK 0001233438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2028-04-30 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 18:20 UTC |
WHITESIDES GEORGE MDirector
|
GrantOrdinary Shares | 8,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006196 · edgar.xml · nonDerivative · entry 1 WHITESIDES GEORGE M · CIK 0001233438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,578 Read SEC document |
| May 01, 2018 Filed May 3, 2018 18:14 UTC |
MALKIEL BURTON GDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $24.43 | $0.00 |
DisclosureSEC source: 0001179110-18-006190 · edgar.xml · derivative · entry 3 MALKIEL BURTON G · CIK 0001184677 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2028-04-30 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 18:14 UTC |
MALKIEL BURTON GDirector
|
GrantOrdinary Shares | 8,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006190 · edgar.xml · nonDerivative · entry 1 MALKIEL BURTON G · CIK 0001184677 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,757 Read SEC document |
| May 01, 2018 Filed May 3, 2018 18:17 UTC |
RINGROSE PETER SDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $24.43 | $0.00 |
DisclosureSEC source: 0001179110-18-006194 · edgar.xml · derivative · entry 2 RINGROSE PETER S · CIK 0001199298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2028-04-30 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 18:17 UTC |
RINGROSE PETER SDirector
|
GrantOrdinary Shares | 8,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006194 · edgar.xml · nonDerivative · entry 1 RINGROSE PETER S · CIK 0001199298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,614 Read SEC document |
| May 01, 2018 Filed May 3, 2018 22:15 UTC |
MITCHELL DEAN JDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $24.43 | $0.00 |
DisclosureSEC source: 0001179110-18-006191 · edgar.xml · derivative · entry 2 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2028-04-30 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 22:15 UTC |
MITCHELL DEAN JDirector
|
GrantOrdinary Shares | 8,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006191 · edgar.xml · nonDerivative · entry 1 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,186 Read SEC document |
| May 01, 2018 Filed May 3, 2018 22:20 UTC |
YOUNG WILLIAM DDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $24.43 | $0.00 |
DisclosureSEC source: 0001179110-18-006197 · edgar.xml · derivative · entry 2 YOUNG WILLIAM D · CIK 0001217420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2028-04-30 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 22:20 UTC |
YOUNG WILLIAM DDirector
|
GrantOrdinary Shares | 8,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006197 · edgar.xml · nonDerivative · entry 1 YOUNG WILLIAM D · CIK 0001217420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,310 Read SEC document |
| May 01, 2018 Filed May 3, 2018 22:11 UTC |
BROSHY ERANDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $24.43 | $0.00 |
DisclosureSEC source: 0001179110-18-006188 · edgar.xml · derivative · entry 2 BROSHY ERAN · CIK 0001256230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2028-04-30 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 22:11 UTC |
BROSHY ERANDirector
|
GrantOrdinary Shares | 8,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006188 · edgar.xml · nonDerivative · entry 1 BROSHY ERAN · CIK 0001256230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,186 Read SEC document |
| May 01, 2018 Filed May 3, 2018 22:16 UTC |
Molineaux SusanDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $24.43 | $0.00 |
DisclosureSEC source: 0001179110-18-006192 · edgar.xml · derivative · entry 3 Molineaux Susan · CIK 0001553389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2028-04-30 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 22:16 UTC |
Molineaux SusanDirector
|
GrantOrdinary Shares | 8,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006192 · edgar.xml · nonDerivative · entry 1 Molineaux Susan · CIK 0001553389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,186 Read SEC document |
| May 01, 2018 Filed May 3, 2018 22:18 UTC |
Smaldone Alsup LaurieDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $24.43 | $0.00 |
DisclosureSEC source: 0001179110-18-006195 · edgar.xml · derivative · entry 2 Smaldone Alsup Laurie · CIK 0001589602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2028-04-30 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 22:18 UTC |
Smaldone Alsup LaurieDirector
|
GrantOrdinary Shares | 8,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006195 · edgar.xml · nonDerivative · entry 1 Smaldone Alsup Laurie · CIK 0001589602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,962 Read SEC document |
| May 01, 2018 Filed May 3, 2018 22:17 UTC |
O'Connor DonalDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $24.43 | $0.00 |
DisclosureSEC source: 0001179110-18-006193 · edgar.xml · derivative · entry 2 O'Connor Donal · CIK 0001625377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2028-04-30 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 22:17 UTC |
O'Connor DonalDirector
|
GrantOrdinary Shares | 8,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006193 · edgar.xml · nonDerivative · entry 1 O'Connor Donal · CIK 0001625377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,186 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 17:39 UTC |
HEGDE SHARATHCHANDRA SSVP, Research
|
Tax withholdingOrdinary Shares | 4,349 | $29.09 | $126,512.41 |
DisclosureSEC source: 0001179110-18-002608 · edgar.xml · nonDerivative · entry 1 HEGDE SHARATHCHANDRA S · CIK 0001668696 · SVP, Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,611 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 17:42 UTC |
WORBOYS PHILIP DSVP, Translational Science
|
Tax withholdingOrdinary Shares | 4,566 | $29.09 | $132,824.94 |
DisclosureSEC source: 0001179110-18-002615 · edgar.xml · nonDerivative · entry 1 WORBOYS PHILIP D · CIK 0001668718 · SVP, Translational Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,563 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 17:40 UTC |
PITZER KENNETH RSVP, Prod Strat & Comm Plng
|
Tax withholdingOrdinary Shares | 4,252 | $29.09 | $123,690.68 |
DisclosureSEC source: 0001179110-18-002611 · edgar.xml · nonDerivative · entry 1 PITZER KENNETH R · CIK 0001668775 · SVP, Prod Strat & Comm Plng 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,054 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 17:41 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
Tax withholdingOrdinary Shares | 5,587 | $29.09 | $162,525.83 |
DisclosureSEC source: 0001179110-18-002612 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,661 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:42 UTC |
Winningham Rick EDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 13,005 | $29.09 | $378,315.45 |
DisclosureSEC source: 0001179110-18-002614 · edgar.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 881,372 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:41 UTC |
SULIMAN SHEHNAAZSVP, Corp Dev & Strategy
|
Tax withholdingOrdinary Shares | 8,770 | $29.09 | $255,119.30 |
DisclosureSEC source: 0001179110-18-002613 · edgar.xml · nonDerivative · entry 1 SULIMAN SHEHNAAZ · CIK 0001713070 · SVP, Corp Dev & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,230 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:40 UTC |
PASQUALONE FRANKSVP, Chief Comm Ops Officer
|
Tax withholdingOrdinary Shares | 4,741 | $29.09 | $137,915.69 |
DisclosureSEC source: 0001179110-18-002610 · edgar.xml · nonDerivative · entry 1 PASQUALONE FRANK · CIK 0001597334 · SVP, Chief Comm Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,619 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:39 UTC |
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc
|
Tax withholdingOrdinary Shares | 8,293 | $29.09 | $241,243.37 |
DisclosureSEC source: 0001179110-18-002607 · edgar.xml · nonDerivative · entry 1 HAUMANN BRETT K · CIK 0001607733 · SVP Clin Dev & Chief Med Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,203 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:38 UTC |
GALA RENEE DSVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 5,387 | $29.09 | $156,707.83 |
DisclosureSEC source: 0001179110-18-002606 · edgar.xml · nonDerivative · entry 1 GALA RENEE D · CIK 0001607737 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,407 Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 22:17 UTC |
Smaldone Alsup LaurieDirector
|
GrantShare Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $28.14 | $0.00 |
DisclosureSEC source: 0001179110-18-002191 · edgar.xml · derivative · entry 3 Smaldone Alsup Laurie · CIK 0001589602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Ordinary Shares · 1,500 shares Expires 2028-02-12 F2 · derivative.exercise_date: This option shall vest monthly over three months of service from the date of grant and in full on the date of the Company's 2018 annual meeting of shareholders. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 22:17 UTC |
Smaldone Alsup LaurieDirector
|
GrantShare Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $28.14 | $0.00 |
DisclosureSEC source: 0001179110-18-002191 · edgar.xml · derivative · entry 2 Smaldone Alsup Laurie · CIK 0001589602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Ordinary Shares · 12,000 shares Expires 2028-02-12 F1 · derivative.exercise_date: The option vests monthly over 24 months of service from the date of grant. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 22:17 UTC |
Smaldone Alsup LaurieDirector
|
GrantOrdinary Shares | 1,776 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002191 · edgar.xml · nonDerivative · entry 1 Smaldone Alsup Laurie · CIK 0001589602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,776 Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 18:20 UTC |
HEGDE SHARATHCHANDRA SSVP, Research
|
GrantOrdinary Shares | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002123 · edgar.xml · nonDerivative · entry 1 HEGDE SHARATHCHANDRA S · CIK 0001668696 · SVP, Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,960 Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 18:24 UTC |
WORBOYS PHILIP DSVP, Translational Science
|
GrantOrdinary Shares | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002132 · edgar.xml · nonDerivative · entry 1 WORBOYS PHILIP D · CIK 0001668718 · SVP, Translational Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,129 Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 18:21 UTC |
PITZER KENNETH RSVP, Prod Strat & Comm Plng
|
GrantOrdinary Shares | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002125 · edgar.xml · nonDerivative · entry 1 PITZER KENNETH R · CIK 0001668775 · SVP, Prod Strat & Comm Plng 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,306 Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 18:22 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
GrantOrdinary Shares | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002127 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,248 Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:23 UTC |
Winningham Rick EDirector · Chief Executive Officer
|
GrantOrdinary Shares | 28,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-002131 · edgar.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 894,377 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.